Palvella Therapeutics Management
Management criteria checks 0/4
Palvella Therapeutics' CEO is Wes Kaupinen, appointed in Dec 2024, has a tenure of less than a year. directly owns 14.32% of the company’s shares, worth €37.01M. The average tenure of the management team and the board of directors is 0.3 years and 0.3 years respectively.
Key information
Wes Kaupinen
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 14.3% |
| Management average tenure | less than a year |
| Board average tenure | less than a year |
Recent management updates
No updates
Recent updates
CEO
Wes Kaupinen
less than a year
Tenure
Mr. Wesley H. Kaupinen, also known as Wes, serves as Chief Executive Officer, Director, Founder and President at Palvella Therapeutics, Inc. from December 2024. He served as Senior Vice President of Corpor...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | less than a year | no data | 14.32% € 37.0m | |
| CFO & Treasurer | less than a year | no data | no data | |
| Chief Operating Officer | less than a year | no data | 0% € 0 | |
| Chief Technical Officer | no data | no data | no data | |
| Chief Scientific Officer | less than a year | no data | 0% € 0 | |
| Vice President of Corporate Development & New Product Planning | no data | no data | no data | |
| Senior Vice President of Clinical Operations | no data | no data | no data | |
| SVP of CMC & Technical Operations | less than a year | no data | no data |
0.3yrs
Average Tenure
51yo
Average Age
Experienced Management: PI6's management team is not considered experienced ( 0.3 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | less than a year | no data | 14.32% € 37.0m | |
| Independent Chairman of the Board | less than a year | no data | 1.61% € 4.2m | |
| Independent Director | 6.5yrs | no data | 0.46% € 1.2m | |
| Independent Director | less than a year | no data | 1% € 2.6m | |
| Independent Director | less than a year | no data | 0% € 0 | |
| Member of Medical & Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific & Clinical Advisory Board | no data | no data | no data | |
| Member of Medical & Scientific Advisory Board | no data | no data | no data | |
| Member of Medical & Scientific Advisory Board | no data | no data | no data | |
| Member of Medical & Scientific Advisory Board | no data | no data | no data | |
| Member of Medical & Scientific Advisory Board | no data | no data | no data | |
| Member of Medical & Scientific Advisory Board | no data | no data | no data |
0.3yrs
Average Tenure
72yo
Average Age
Experienced Board: PI6's board of directors are not considered experienced ( 0.3 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/11 14:58 |
| End of Day Share Price | 2025/03/11 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Palvella Therapeutics, Inc. is covered by 4 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Whitney Ijem | Canaccord Genuity |
| Joshua Schimmer | Cantor Fitzgerald & Co. |
| Andrew Fein | H.C. Wainwright & Co. |